By The Nation
Qiagen has announced its expansion in Thailand and opened an office in Bangkok to enhance relationships with life science researchers and healthcare providers in the growing market.
Qiagen is involved in two new collaborations: a molecular techniques centre established with the faculty for tropical medicine at Mahidol University, and a collaboration with Ramathibodi Hospital to study genomic insights from next-generation sequencing (NGS).
“We are pleased to expand our commitment to the people of Thailand, where we have built relationships with medical institutions and the government for more than 16 years. As we open our new Bangkok office, we are also introducing new collaborations with two of the country’s leading medical institutions,” said William Lin, Qiagen Thailand’s director of commercial Operations. “We look forward to providing Thai scientists and healthcare providers with innovative Sample to Insight solutions for molecular testing, including our NGS solutions, as we seek to make improvements in life possible.”
The collaboration with Mahidol University has established the Qiagen–TropMed Centre for Molecular Techniques in conjunction with the Faculty of Tropical Medicine to support research using molecular biology techniques.
“We are happy to join with Qiagen in creating the TropMed Centre for Molecular Techniques to bring the benefits of genomic insights to research on malaria and other diseases. Our partnership will demonstrate the potential of academic-industry collaboration, as well as educate the younger generation in techniques of molecular biology,” said Dr Wang Nguitragool, assistant professor, Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine of Mahidol University.